Target intelligence / Profile preview

RNA polymerase beta subunit (bacterial) (β subunit (bacterial RNAP) or RpoB)

Target
β subunit (bacterial RNAP) or RpoB
Molecular classification
Enzyme, Transcription factor (as part of RNA polymerase enzyme complex), Polymerase
01

Overview

The **bacterial RNA polymerase beta subunit** (commonly referred to as the **β subunit** or **RpoB**) is one of the core subunits of the bacterial DNA-dependent RNA polymerase enzyme complex, which catalyzes the synthesis of RNA from a DNA template during transcription[3][7][8]. The β subunit, encoded by the rpoB gene, forms part of the catalytic center with the β′ subunit and provides key sites for the binding of DNA, nascent RNA, and for the action of crucial antibiotics[3][8]. It is a major target of rifampicin and related drugs, and specific mutations in rpoB lead to drug resistance, making it clinically significant for the treatment and monitoring of bacterial infections, especially tuberculosis[3]. The β subunit’s structure plays a central role in coordinating catalytic activity, facilitating nucleic acid interactions, and interacting with transcriptional regulators and inhibitors[5][7][8].

Other names
RNA polymerase β subunitRpoBDNA-directed RNA polymerase subunit beta (bacterial)RNAP betaRNAP β
02

Mechanism of action

Inhibition of RNA synthesis by binding to the beta subunit and blocking the formation of the RNA chain (e.g., rifampicin binds to β subunit, preventing elongation of RNA transcript)

03

Biological functions

Catalyzes DNA-dependent RNA synthesisTranscription of bacterial genesForms part of the catalytic core of RNA polymeraseInvolved in the binding and stabilization of DNA/RNA hybrid during transcription
04

Disease associations

Infection (antibacterial drug target)
05

Safety considerations

Resistance mutations in rpoB can lead to clinical antibiotic resistance, complicating treatment of infections like tuberculosisNot directly associated with human toxicity, as the target is bacterial-specific, but misuse or overuse of drugs increases resistance risk
06

Interacting drugs

Rifampicin (also called rifampin)

3 more in the full profile.

07

Biomarkers

rpoB mutations as biomarkers for rifampicin resistance in Mycobacterium tuberculosis and other bacteria

Beyond the preview

Go deeper on RNA polymerase beta subunit (bacterial) (β subunit (bacterial RNAP) or RpoB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase beta subunit (bacterial) (β subunit (bacterial RNAP) or RpoB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call